相似文献
1
Does microbial resistance matter?
Lancet Infect Dis. 2011 Jan;11(1):3-4. doi: 10.1016/S1473-3099(10)70287-5. Epub 2010 Dec 2.
2
Clinical impact of antimicrobial resistance: design matters.
Lancet Infect Dis. 2011 May;11(5):344; author reply 344-5. doi: 10.1016/S1473-3099(11)70107-4.
3
[Extended spectrum beta lactamase forming pathogens (ESBL)].
Med Klin Intensivmed Notfmed. 2012 Nov;107(8):592-3. doi: 10.1007/s00063-012-0185-z.
4
Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop.
N Engl J Med. 1994 Apr 28;330(17):1247-51. doi: 10.1056/NEJM199404283301725.
5
[Bacterial contamination in a polyvalent resuscitation department and resistance of the bacteria to antibiotics].
Ann Anesthesiol Fr. 1974;15(3):215-22.
6
Multiresistance and 'superbugs'.
Commun Dis Public Health. 1998 Jun;1(2):74-6.
7
[The magnitude of in-hospital drug resistance].
Rev Esp Quimioter. 2006 Mar;19(1):81-2.
8
Antibiotic therapy and microbiologic considerations in the intensive care unit.
Kidney Int Suppl. 1998 May;66:S87-90.
9
[Antibiotic resistance: development in surgical intensive care].
Zentralbl Chir. 2011 Apr;136(2):143-51. doi: 10.1055/s-0030-1262609. Epub 2011 Feb 24.
10
The bacteria fight back.
Science. 2008 Jul 18;321(5887):356-61. doi: 10.1126/science.321.5887.356.
Zotero 插件